Positron emission tomography/computed tomography in locally advanced breast cancer
Locally advanced breast cancer (LABC) is a relatively small group of breast cancer, but is significant because it carries a higher risk of locoregional recurrence and distant metastasis. The accepted approach for these patients is neoadjuvant chemotherapy before surgery as determining the response t...
Збережено в:
| Опубліковано в: : | Experimental Oncology |
|---|---|
| Дата: | 2013 |
| Автор: | |
| Формат: | Стаття |
| Мова: | Англійська |
| Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2013
|
| Теми: | |
| Онлайн доступ: | https://nasplib.isofts.kiev.ua/handle/123456789/145235 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Цитувати: | Positron emission tomography/computed tomography in locally advanced breast cancer / E. Ozkan // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 253-257. — Бібліогр.: 52 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraine| _version_ | 1862738142979686400 |
|---|---|
| author | Ozkan, E. |
| author_facet | Ozkan, E. |
| citation_txt | Positron emission tomography/computed tomography in locally advanced breast cancer / E. Ozkan // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 253-257. — Бібліогр.: 52 назв. — англ. |
| collection | DSpace DC |
| container_title | Experimental Oncology |
| description | Locally advanced breast cancer (LABC) is a relatively small group of breast cancer, but is significant because it carries a higher risk of locoregional recurrence and distant metastasis. The accepted approach for these patients is neoadjuvant chemotherapy before surgery as determining the response to therapy in the early stages is of critical importance in respect of the approach taken to the disease. Positron emission tomography/computed tomography (PET/CT) using fluorine-18-fluorodeoxyglucose (18F-FDG) is currently used for staging, restaging and response monitoring in breast cancer. The areas of use of FDG PET/CT in LABC can be summarised as the evaluation of response to neoadjuvant chemotherapy in the early stage in particular, and the determination of unexpected areas of metastasis not detected by standard imaging techniques. There are current ongoing studies on promising new PET radiopharmaceuticals apart from FDG.
|
| first_indexed | 2025-12-07T20:02:51Z |
| format | Article |
| fulltext | |
| id | nasplib_isofts_kiev_ua-123456789-145235 |
| institution | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| issn | 1812-9269 |
| language | English |
| last_indexed | 2025-12-07T20:02:51Z |
| publishDate | 2013 |
| publisher | Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
| record_format | dspace |
| spelling | Ozkan, E. 2019-01-19T17:52:24Z 2019-01-19T17:52:24Z 2013 Positron emission tomography/computed tomography in locally advanced breast cancer / E. Ozkan // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 253-257. — Бібліогр.: 52 назв. — англ. 1812-9269 https://nasplib.isofts.kiev.ua/handle/123456789/145235 Locally advanced breast cancer (LABC) is a relatively small group of breast cancer, but is significant because it carries a higher risk of locoregional recurrence and distant metastasis. The accepted approach for these patients is neoadjuvant chemotherapy before surgery as determining the response to therapy in the early stages is of critical importance in respect of the approach taken to the disease. Positron emission tomography/computed tomography (PET/CT) using fluorine-18-fluorodeoxyglucose (18F-FDG) is currently used for staging, restaging and response monitoring in breast cancer. The areas of use of FDG PET/CT in LABC can be summarised as the evaluation of response to neoadjuvant chemotherapy in the early stage in particular, and the determination of unexpected areas of metastasis not detected by standard imaging techniques. There are current ongoing studies on promising new PET radiopharmaceuticals apart from FDG. en Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України Experimental Oncology Special issue on breast cancer Positron emission tomography/computed tomography in locally advanced breast cancer Article published earlier |
| spellingShingle | Positron emission tomography/computed tomography in locally advanced breast cancer Ozkan, E. Special issue on breast cancer |
| title | Positron emission tomography/computed tomography in locally advanced breast cancer |
| title_full | Positron emission tomography/computed tomography in locally advanced breast cancer |
| title_fullStr | Positron emission tomography/computed tomography in locally advanced breast cancer |
| title_full_unstemmed | Positron emission tomography/computed tomography in locally advanced breast cancer |
| title_short | Positron emission tomography/computed tomography in locally advanced breast cancer |
| title_sort | positron emission tomography/computed tomography in locally advanced breast cancer |
| topic | Special issue on breast cancer |
| topic_facet | Special issue on breast cancer |
| url | https://nasplib.isofts.kiev.ua/handle/123456789/145235 |
| work_keys_str_mv | AT ozkane positronemissiontomographycomputedtomographyinlocallyadvancedbreastcancer |